Prothena Corp Public (PRTA) Return on Capital Employed Growth (3y) (2016 - 2026)

Prothena Corp Public (PRTA) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4,893.00
4 NuCana 279.75 Bn 279.75 Bn - 2,416.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -494.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -649.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -3,782.00
10 Prothena Corp Public 458.13 Mn 128.67 Mn - -1,753.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,753.00
Dec 31, 2025 -5,011.00
Sep 30, 2025 -4,588.00
Jun 30, 2025 -7,327.00
Mar 31, 2025 -4,115.00
Dec 31, 2024 -4,182.00
Sep 30, 2024 -4,409.00
Jun 30, 2024 284.00
Mar 31, 2024 97.00
Dec 31, 2023 665.00
Sep 30, 2023 1,403.00
Jun 30, 2023 -41.00
Mar 31, 2023 94.00
Dec 31, 2022 -117.00
Sep 30, 2022 -1,277.00
Jun 30, 2022 1,950.00
Mar 31, 2022 4,050.00
Dec 31, 2021 4,423.00
Sep 30, 2021 5,004.00
Jun 30, 2021 2,107.00